- Early diagnosis and recognition of organ involvement with immediate intervention can help decrease the morbidity and mortality in Behcet disease.

- Treatment varies according to the patient's sex, presentation, and preference.

- The duration of treatment is not known. However, immunosuppressive therapy for at least 18 to 24 months is usually recommended in refractory illness.

- Hematopoietic stem cell transplantation and granulocytapheresis are being investigated as therapy.